Motavizumab for prophylaxis of respiratory syncytial virus in high-risk children: a noninferiority trial.

Saved in:
Bibliographic Details
Title: Motavizumab for prophylaxis of respiratory syncytial virus in high-risk children: a noninferiority trial.
Authors: Carbonell-Estrany X; Neonatology Service, Hospital Clínic, Agrupació Sanitèria Clínic, Hospital de Sant Joan de Déu, Barcelona, Spain. xcarbo@clinic.ub.es, Simões EA, Dagan R, Hall CB, Harris B, Hultquist M, Connor EM, Losonsky GA
Corporate Authors: Motavizumab Study Group
Source: Pediatrics [Pediatrics] 2010 Jan; Vol. 125 (1), pp. e35-51. Date of Electronic Publication: 2009 Dec 14.
Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
Journal Info: Publisher: American Academy of Pediatrics Country of Publication: United States NLM ID: 0376422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-4275 (Electronic) Linking ISSN: 00314005 NLM ISO Abbreviation: Pediatrics Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1098-4275
DOI:10.1542/peds.2008-1036